Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
26.34
+0.09 (0.34%)
Aug 10, 2026, 2:15 PM EDT - Market open
Dyne Therapeutics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Dyne Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $39.4. The average 1-year stock price forecast is 49.58% higher than the current stock price, while the lowest is $17 (-35.46%) and the highest is $50 (+89.83%).
Price Target: $39.4 (+49.58%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dyne Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 13 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $40 | Buy | Maintains | $40 | +51.86% | Aug 5, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $37 | Buy | Maintains | $37 | +40.47% | Jul 31, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $30 → $35 | Buy | Reiterates | $30 → $35 | +32.88% | Jul 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $47 | Buy | Reiterates | $47 | +78.44% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
51.30M
EPS This Year
-3.55
from -3.47
EPS Next Year
-3.26
from -3.55
EPS and Forward PE are based on non-GAAP adjusted numbers.